For two decades, our founder and director Amanda Feilding has been one of the most prominent voices speaking out against the harms and injustices wrought by global drug policy, as well as one of the most active players advancing psychedelic research. In demand as a speaker among lawmakers, scientists, and public audiences, she has spoken before diverse audiences – ranging from the House of Lords, to local activist groups. A selection of her talks can be seen below..
A Psycho-vitamin to give more energy to the brain
In June 2018, Amanda spoke at the Beyond Psychedelics convention in Prague.
In this interview with psychedelic researcher David Luke, she explains the enormous potential that psychedelics possess, and outlines current and upcoming research at the Beckley Foundation.
From Problem Child to Wonder Child: An Evolving Story…
On Bicycle Day 2018, Amanda Feilding addressed the LSD75.CH Symposium in Basel. In her speech, ‘From Problem Child to Wonder Child: An Evolving Story..’, she reflects on her memories of Albert Hofmann, her research into psychedelic medicines, and the future she envisions for LSD in both science and culture. Read more here.
Why Science Needs Psychedelics: A Paradigm Shift for Psychiatry
In April 2018, Amanda presented “Why Science Needs Psychedelics: A Paradigm Shift for Psychiatry” at the 5th Session of the World Congress for Freedom of Scientific Research. This conference, hosted in the European Parliament, focused on individual rights to benefit from science, and the freedom to perform medical research and receive medical treatment. Read more here.
From the Mystical Experience to Microdosing
Horizons: Perspectives on Psychedelics is an annual forum that examines the role of psychedelic drugs science, medicine, culture, and spirituality. In 2017, Amanda Feilding presented her talk ‘From the Mystical Experience to Microdosing’, where she explored the mystical experiences in her own life which lead her to dedicate her life to psychedelic research.
From Taboo to Treatment: The Coming of Age of Psychedelic Medicine
In 2017, the Beckley Foundation together with MAPS co-hosted Psychedelic Science. The international scientific community came together in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, cannabis, and other emerging treatments in psychedelics science. Here, Amanda presents her talk “From Taboo to Treatment: The Coming of Age of Psychedelic Medicine”.
Psilocybin for Depression
Type of publication